Article Versions Notes

Fanciulli G, Modica R, La Salvia A, Campolo F, Florio T, Mikovic N, Plebani A, Di Vito V, Colao A, Faggiano A on behalf of NIKE Group . Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? Cancers. 2022; 14(16):3991. https://doi.org/10.3390/cancers14163991

Fanciulli, Giuseppe, Roberta Modica, Anna La Salvia, Federica Campolo, Tullio Florio, Nevena Mikovic, Alice Plebani, Valentina Di Vito, Annamaria Colao, and Antongiulio Faggiano on behalf of NIKE Group . 2022. "Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?" Cancers 14, no. 16: 3991. https://doi.org/10.3390/cancers14163991

Fanciulli, G., Modica, R., La Salvia, A., Campolo, F., Florio, T., Mikovic, N., Plebani, A., Di Vito, V., Colao, A., & Faggiano, A., on behalf of NIKE Group . (2022). Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? Cancers, 14(16), 3991. https://doi.org/10.3390/cancers14163991